About Evosep
Evosep is a company based in Odense (Denmark) founded in 2016 by Ole Vorm was acquired by Nordic Capital in November 2025.. Evosep has raised $48.78 million across 5 funding rounds from investors including Novo Holdings and Nordic Capital. Evosep offers products and services including Evosep One, Evotip, and Columns and Emitters. Evosep operates in a competitive market with competitors including Ovizio, Curiox, Pressure BioSciences, inveox and AcouSort, among others.
- Headquarter Odense, Denmark
- Founders Ole Vorm
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Evosep Aps
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$48.78 M (USD)
in 5 rounds
-
Latest Funding Round
$42.57 M (USD), Series A
Jan 09, 2023
-
Investors
Novo Holdings
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Nordic Capital
(Nov 18, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Evosep
Evosep offers a comprehensive portfolio of products and services, including Evosep One, Evotip, and Columns and Emitters. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for standardized, high-speed clinical proteomics analysis.
Tool that speeds up sample loading and reduces carry-over in proteomics.
Components for enhancing liquid chromatography in research applications.
Unlock access to complete
Funding Insights of Evosep
Evosep has successfully raised a total of $48.78M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $42.57 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $42.6M
-
First Round
First Round
(30 Jun 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Series A - Evosep | Valuation | Novo Holdings |
|
| Dec, 2018 | Amount | Seed - Evosep | Valuation |
investors |
|
| Jan, 2018 | Amount | Seed - Evosep | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Evosep
Evosep has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Novo Holdings and Nordic Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Evosep
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Evosep
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Evosep Comparisons
Competitors of Evosep
Evosep operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ovizio, Curiox, Pressure BioSciences, inveox and AcouSort, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Imaging systems and AI software for microscopes are developed.
|
|
| domain | founded_year | HQ Location |
Wall-less plates and washers are developed for automated cell-based assays.
|
|
| domain | founded_year | HQ Location |
Biomolecular reactions are controlled via pressure cycling technology.
|
|
| domain | founded_year | HQ Location |
Automated solutions for biopsy sample preparation in laboratories are provided.
|
|
| domain | founded_year | HQ Location |
Microfluidic acoustofluidics technology for cell separation is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Evosep
Frequently Asked Questions about Evosep
When was Evosep founded?
Evosep was founded in 2016.
Where is Evosep located?
Evosep is headquartered in Odense, Denmark.
Is Evosep a funded company?
Evosep is a funded company, having raised a total of $48.78M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1.68M, raised on Jun 30, 2016.
What does Evosep do?
Evosep was founded in 2016 in Odense, Denmark, and operates within the clinical proteomics sector. Integrated systems for sample separation and purification are provided through products such as the Evosep One platform and disposable Evotips trap-columns. These enable desalting and cleaning of samples for chromatography analysis. Applications encompass diagnostics, biomarker discovery in humans and plants, and related fields in proteomics research.
What products or services does Evosep offer?
Evosep offers Evosep One, Evotip, and Columns and Emitters.
Who are Evosep's investors?
Evosep has 2 investors. Key investors include Novo Holdings, and Nordic Capital.
What is Evosep's valuation?
The valuation of Evosep is $8.84M as of Dec 2018.